Skip to main content
SpringerLink
Log in

Atypical hyperplasia and breast cancer risk: a critique

  • Research Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

The purpose of this paper is to examine critically the evidence that atypical hyperplasia (AH) is a risk factor for breast cancer. First, we appraised studies that have examined the association between AH and breast cancer risk for their adherence to widely accepted standards for the conduct of research. Second, we examined the a vailable evidence to determine the plausibility of an association between AH and breast cancer risk using the guidelines proposed by Bradford Hill. A total of 18 studies (11 cohort studies, two case-control studies, and five cross-sectional studies) were found that were published in the English language from January 1960 to March 1992 that examined the association of AH as a distinct entity and breast cancer risk. A systematic approach was adopted to examine the collected studies for their adherence to methodologic standards, which showed wide variation among studies. A meta-analysis was carried out, based on a total sample size of 182,980 women. Of 16 studies that gave point estimates of risk, 14 exceeded unity and 12 were significantly different from unity. The pooled estimate from all studies of the association between AH and breast cancer, gave an overall odds ratio (OR) of 3.67 (95 percent confidence interval = 3.16–4.26). The test of the hypothesis of homogeneous association was rejected (χ2 = 151.6, df = 14, P<0.0001), indicating significant variability among the ORs of individual studies. The conclusions from the application of the Bradford Hill criteria indicated strongly that AH is a risk factor for breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kelsey JL, Berkowitz GS. Breast cancer epidemiology. Cancer Res 1988; 48: 5615–23.

    Google Scholar 

  2. Kelsey JL. A review of the epidemiology of human breast cancer. Epidemiol Rev (Johns Hopkins University School of Hygiene and Public Health) 1979; 1: 74–109.

    Google Scholar 

  3. Hill Sir AB. Statistical evidence and inference. In: Hill Sir AB. Principles of Medical Statistics, 9th Edn. London: Oxford University Press, 1971: 309–23.

    Google Scholar 

  4. Ashikari R, Huvos AG, Snyder RE, et al. A clinicopathologic study of atypical lesions of the breast. Cancer 1974; 33: 310–7.

    Google Scholar 

  5. Kodlin D, Winger EE, Morgenstern NL, Chen U. Chronic mastopathy and breast cancer: a follow-up study. Cancer 1977; 39: 2603–7.

    Google Scholar 

  6. Harvey DG, Fechner RE. Atypical lobular and papillary lesions of the breast: a follow-up study of 30 cases. South Med J 1978; 71: 361–4.

    Google Scholar 

  7. Moskowitz M, Gartside P, Wirman JA, McLaughlin C. Proliferative disorders of the breast as risk factors for breast cancer in a self-selected screened population: pathologic markers. Radiology 1980; 134: 289–91.

    Google Scholar 

  8. Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B. Risk of breast cancer in women with benign breast disease. JNCI 1980; 65: 13–20.

    Google Scholar 

  9. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146–51.

    Google Scholar 

  10. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988; 128: 467–77.

    Google Scholar 

  11. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992; 267: 941–4.

    Google Scholar 

  12. Palli D, Rosselli del Turco M, Simoncini R, Bianchi S. Benign breast disease and breast cancer. A case-control study in a cohort in Italy. Int J Cancer 1991; 47: 703–6.

    Google Scholar 

  13. Ris HB, Niederer U, Stirnemann H, Doran JE, Zimmermann A. Long-term follow-up of patients with biopsyproven benign breast disease. Ann Surg 1988; 207: 404–9.

    Google Scholar 

  14. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990; 65: 518–29.

    Google Scholar 

  15. Black MM, Barclay TH, Cutler SJ, Hankey BF, Asire AJ. Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer 1972; 29: 338–43.

    Google Scholar 

  16. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D. Histologic types of benign breast disease and the risk for breast cancer. Cancer 1992; 69: 1408–14.

    Google Scholar 

  17. Kern WH, Brooks RN. Atypical epithelial hyperplasia associated with breast cancer and fibrocystic disease. Cancer 1969; 24: 668–75.

    Google Scholar 

  18. Karpas CM, Leis HP, Oppenheim A, Mersheimer WL. Relationship of fibrocystic disease to carcinoma of the breast. Ann Surg 1965; 162: 1–8.

    Google Scholar 

  19. Ryan JA, Coady CJ. Intraductual epithelial proliferation in the human breast—a comparative study. Can J Surg 1962; 5: 12–19.

    Google Scholar 

  20. Tellem M, Prive L, Meranze DR. Four-quadrant study of breasts removed for carcinoma. Cancer 1962; 15: 10–17.

    Google Scholar 

  21. Alpers CE, Wellings SR. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Human Pathol 1985; 16: 796–807.

    Google Scholar 

  22. Webber W, Boyd N. A critique of the methodology of studies of benign breast disease and breast cancer risk. JNCI 1986; 77: 397–404.

    Google Scholar 

  23. Schlesselman JJ. Case Control Studies: Design, Conduct and Analysis. New York City: Oxford University Press, 1982.

    Google Scholar 

  24. Cardiff RD, Wellings SR, Faulkin LJ. Biology of breast preneoplasia. Cancer 1977; 39: 2734–46.

    Google Scholar 

  25. Gallager HS, Martin JE. Early phases in the development of breast cancer. Cancer 1969; 24: 1170–8.

    Google Scholar 

  26. Medina D. Preneoplastic lesions in mouse mammary-tumorigenesis. In: Busch H, ed. Methods in Cancer Research, Vol. 7. New York: Academic Press, 1973: 1–53.

    Google Scholar 

  27. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. JNCI 1975; 55: 231–73.

    Google Scholar 

  28. Squartini F, Sarnelli R. Structure, functional changes, and proliferative pathology of the human mammary lobule in cancerous breasts. JNCI 1981; 67: 33–46.

    Google Scholar 

  29. Louis TA, Fineberg HV, Mosteller F. Findings for public health from meta-analyses. Annu Rev Public Health 1985; 6: 1–20.

    Google Scholar 

  30. Cytel Software Corporation. Stat Xact. Statistical Software for Exact Non-parametric Inference. Cambridge, MA: Cytel Software Corporation, 1989.

    Google Scholar 

  31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7: 177–88.

    Google Scholar 

  32. Breslow NE, Day NE. Statistical Methods in Cancer Research. The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980; IARC Sci. Pub. No. 32.

    Google Scholar 

  33. Black MM, Chabon AB. In situ carcinoma of the breast. In: Sommers SC, ed. Pathology Annual. New York: Appleton-Century-Crofts, 1969: 185–210.

    Google Scholar 

  34. Ohuchi N, Page DL, Merino MJ, Viglione MJ, Rufe DW, Schlom J. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast. JNCI 1987; 79: 109–17.

    Google Scholar 

  35. Nenci I, Marchetti E, Querzoli P. Commentary on human mammary preneoplasia. The estrogen-receptor-promotion hypothesis. J Steroid Biochem 1988; 30: 105–6.

    Google Scholar 

  36. Hsieh CC, Walker AM, Trapido EJ, Crosson AW, MacMahon B. Age at first birth and breast atypia. Int J Cancer 1984; 33: 309–12.

    Google Scholar 

  37. Berkowitz GS, Kelsey JL, LiVolsi VA, et al. Risk factors for fibrocystic breast disease and its histopathologic components. JNCI 1985; 75: 43–50.

    Google Scholar 

  38. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer 1985; 55: 2698–708.

    Google Scholar 

  39. Dupont WD, Page DL. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 1987; 125: 769–79.

    Google Scholar 

  40. Dupont WD, Page DL, Rogers LW, Parl FF. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 1989; 63: 948–57.

    Google Scholar 

  41. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Reviews 1987; 9: 1–30.

    Google Scholar 

  42. Schnitt SJ, Wang HH. Histologic sampling of grossly benign breast biopsies. How much is enough? Am J Surg Pathol 1989; 13: 505–12.

    Google Scholar 

  43. Schuerch C, Rosen PP, Hirota T et al. A pathologic study of benign breast diseases in Tokyo and New York. Cancer 1982; 50: 1899–903.

    Google Scholar 

  44. Beck JS. Observer variability in reporting of breast lesions. J Clin Pathol 1985; 38: 1358–65.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Epidemiology and Statistics, Ontario Cancer Institute, 500 Sherbourne St, M4X 1K9, Toronto, Ontario, Canada

    L. Ma & N. F. Boyd

Authors
  1. L. Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. F. Boyd
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ma, L., Boyd, N.F. Atypical hyperplasia and breast cancer risk: a critique. Cancer Causes Control 3, 517–525 (1992). https://doi.org/10.1007/BF00052748

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00052748

Key words

Search

Navigation